Intelligence Profile
Clinical Applications
Enclomiphene is primarily investigated for the treatment of male hypogonadism and testosterone deficiency, with emerging evidence supporting its use as an alternative to traditional testosterone replacement therapy.
Male Hypogonadism and Testosterone Deficiency
The primary clinical application for enclomiphene is in treating male hypogonadism. A systematic review and meta-analysis of randomized controlled trials examining clomiphene or enclomiphene citrate for male hypogonadism was published in 2025, though the specific findings from this analysis are not detailed in the available evidence.
A retrospective case series of 15 men examined sublingual enclomiphene citrate combined with a mineral oxide delivery system, reporting changes in serum testosterone levels. However, the specific efficacy data from this study is not provided in the available evidence.
Spermatogenesis Preservation
Enclomiphene shows promise in preserving spermatogenesis in men with testosterone deficiency. This represents a significant advantage over traditional testosterone replacement therapy, which typically suppresses natural sperm production. The compound is being studied as part of innovations in both replacement and stimulatory therapies for maintaining fertility while addressing testosterone deficiency.
Post-Cycle Therapy Applications
There is emerging interest in using clomiphene citrate (which includes enclomiphene as an isomer) for off-label post-cycle therapy following anabolic steroid use. This application focuses on endocrine recovery, though the evidence notes diagnostic challenges in this context.
Professional Recognition and Guidelines
The British Society of Sexual Medicine has issued a position statement regarding the potential use of enclomiphene in treating male hypogonadism, indicating growing professional recognition of this therapeutic approach.
Evidence Limitations
The available evidence consists primarily of position statements, case series, and systematic reviews without detailed outcome data. While multiple studies are referenced, specific efficacy rates, safety profiles, and comparative effectiveness data are not provided in the current evidence base. More robust clinical trial data would be needed to fully characterize the clinical utility of enclomiphene across these applications.
Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Consult with a qualified healthcare provider for personalized treatment recommendations.